Danaher Co. (NYSE:DHR) is Defender Capital LLC.’s 2nd Largest Position

Defender Capital LLC. lowered its stake in shares of Danaher Co. (NYSE:DHR) by 6.4% in the second quarter, according to its most recent 13F filing with the SEC. The fund owned 148,916 shares of the conglomerate’s stock after selling 10,215 shares during the period. Danaher comprises about 17.2% of Defender Capital LLC.’s portfolio, making the stock its 2nd largest holding. Defender Capital LLC.’s holdings in Danaher were worth $21,219,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cornerstone Advisors Inc. boosted its stake in shares of Danaher by 2.9% in the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock worth $367,000 after acquiring an additional 79 shares during the period. Signaturefd LLC boosted its stake in shares of Danaher by 16.2% in the first quarter. Signaturefd LLC now owns 6,867 shares of the conglomerate’s stock worth $907,000 after acquiring an additional 959 shares during the period. Banyan Capital Management Inc. bought a new position in shares of Danaher in the first quarter worth about $5,287,000. Jackson Wealth Management LLC boosted its stake in shares of Danaher by 0.7% in the first quarter. Jackson Wealth Management LLC now owns 17,920 shares of the conglomerate’s stock worth $2,366,000 after acquiring an additional 131 shares during the period. Finally, Resource Management LLC boosted its stake in shares of Danaher by 10.8% in the first quarter. Resource Management LLC now owns 5,427 shares of the conglomerate’s stock worth $716,000 after acquiring an additional 527 shares during the period. Institutional investors and hedge funds own 78.43% of the company’s stock.

In related news, Chairman Mitchell P. Rales acquired 2,500 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were acquired at an average cost of $139.52 per share, for a total transaction of $348,800.00. Following the completion of the transaction, the chairman now directly owns 3,030,453 shares in the company, valued at approximately $422,808,802.56. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CAO Robert S. Lutz sold 14,668 shares of the company’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $143.28, for a total value of $2,101,631.04. Following the sale, the chief accounting officer now owns 21,054 shares in the company, valued at $3,016,617.12. The disclosure for this sale can be found here. Insiders sold 177,202 shares of company stock worth $25,175,829 over the last quarter. 11.40% of the stock is owned by company insiders.

Shares of NYSE:DHR traded up $3.41 during mid-day trading on Monday, reaching $144.97. The stock had a trading volume of 112,393 shares, compared to its average volume of 2,293,766. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33. The company has a market cap of $102.41 billion, a P/E ratio of 32.02, a price-to-earnings-growth ratio of 2.58 and a beta of 0.94. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $147.33. The business’s 50 day moving average price is $141.00 and its 200 day moving average price is $136.55.

Danaher (NYSE:DHR) last posted its earnings results on Thursday, July 18th. The conglomerate reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. The company had revenue of $5.16 billion for the quarter, compared to the consensus estimate of $5.09 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the business earned $1.15 earnings per share. Analysts predict that Danaher Co. will post 4.79 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, September 27th will be given a $0.17 dividend. The ex-dividend date is Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.47%. Danaher’s dividend payout ratio is currently 15.04%.

DHR has been the subject of a number of recent analyst reports. Argus upped their price objective on Danaher to $165.00 and gave the stock a “buy” rating in a research note on Tuesday, July 23rd. Robert W. Baird upped their price objective on Danaher from $131.00 to $148.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Needham & Company LLC reaffirmed a “buy” rating and issued a $155.00 price objective (up previously from $142.00) on shares of Danaher in a research note on Friday, July 19th. Piper Jaffray Companies upped their price objective on Danaher from $148.00 to $153.00 and gave the stock a “neutral” rating in a research note on Thursday, July 18th. Finally, Royal Bank of Canada set a $134.00 price objective on Danaher and gave the stock a “hold” rating in a research note on Friday, July 19th. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $143.54.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: Terms to Better Understand Call Options

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.